PACIRA BIOSCIENCES, INC. Income (Loss) from Continuing Operations before Income Taxes, Domestic
PACIRA BIOSCIENCES, INC. (PCRX) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of $5.95 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-08-04
- PACIRA BIOSCIENCES, INC. income (loss) from continuing operations before income taxes, domestic for the quarter ending 2026-06-30 was $5.95M.
- PACIRA BIOSCIENCES, INC. income (loss) from continuing operations before income taxes, domestic for the quarter ending 2026-03-31 was $4.17M, a 60.96% decline year-over-year.
- PACIRA BIOSCIENCES, INC. income (loss) from continuing operations before income taxes, domestic for the quarter ending 2025-12-31 was $2.66M, a 89.07% decline year-over-year.
- PACIRA BIOSCIENCES, INC. income (loss) from continuing operations before income taxes, domestic for the quarter ending 2025-09-30 was $10.50M.
- PACIRA BIOSCIENCES, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was $19.61M.
- PACIRA BIOSCIENCES, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$65.33M, a 198.59% decline from fiscal 2023.
- PACIRA BIOSCIENCES, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was $66.26M, a 214.49% increase from fiscal 2022.
- PACIRA BIOSCIENCES, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was $21.07M, a 67.46% decline from fiscal 2021.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 3 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 3 month as first filed | Income (Loss) from Continuing Operations before Income Taxes, Domestic 6 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 9 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 9 month as first filed | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $5.95M 10-Q · filed 2026-08-04 | $10.11M 10-Q · filed 2026-08-04 | $12.77M derived: sum of 3 quarters · filed 2026-08-04 | $23.27M derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2026-03-31 | $4.17M 10-Q · filed 2026-04-30 | $6.83M derived: sum of 2 quarters · filed 2026-04-30 | $17.32M derived: sum of 3 quarters · filed 2026-04-30 | $13.11M derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2025-12-31 | $2.66M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $13.16M derived: sum of 2 quarters · filed 2026-02-26 | $8.94M derived: sum of 3 quarters · filed 2026-08-04 | $19.61M 10-K · filed 2026-02-26 | |||
| 2025-09-30 | $10.50M 10-Q · filed 2025-11-06 | $6.28M derived: sum of 2 quarters · filed 2026-08-04 | $16.96M 10-Q · filed 2025-11-06 | $41.29M derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2025-06-30 | -$4.21M 10-Q · filed 2026-08-04 | $6.46M 10-Q · filed 2026-08-04 | $30.79M derived: sum of 3 quarters · filed 2026-08-04 | -$109.52M derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2025-03-31 | $10.67M 10-Q · filed 2026-04-30 | $35.00M derived: sum of 2 quarters · filed 2026-04-30 | -$105.31M derived: sum of 3 quarters · filed 2026-04-30 | -$68.31M derived: sum of 4 quarters · filed 2026-04-30 | |||
| 2024-12-31 | $24.33M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$115.98M derived: sum of 2 quarters · filed 2026-02-26 | -$78.98M derived: sum of 3 quarters · filed 2026-02-26 | -$65.33M 10-K · filed 2026-02-26 | |||
| 2024-09-30 | -$140.31M 10-Q · filed 2025-11-06 | -$103.31M derived: sum of 2 quarters · filed 2025-11-06 | -$89.66M 10-Q · filed 2025-11-06 | -$52.45M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-06-30 | $37.00M 10-Q · filed 2025-08-05 | $50.65M 10-Q · filed 2025-08-05 | $87.86M derived: sum of 3 quarters · filed 2026-02-26 | $104.49M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-03-31 | $13.66M 10-Q · filed 2025-05-08 | $50.87M derived: sum of 2 quarters · filed 2026-02-26 | $67.50M derived: sum of 3 quarters · filed 2026-02-26 | $107.69M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2023-12-31 | $37.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $53.84M derived: sum of 2 quarters · filed 2026-02-26 | $94.03M derived: sum of 3 quarters · filed 2026-02-26 | $66.26M 10-K · filed 2026-02-26 | |||
| 2023-09-30 | $16.63M 10-Q · filed 2024-11-06 | $56.82M derived: sum of 2 quarters · filed 2024-11-06 | $29.05M 10-Q · filed 2024-11-06 | $10.51M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2023-06-30 | $40.19M 10-Q · filed 2024-07-30 | $12.42M 10-Q · filed 2024-07-30 | -$6.13M derived: sum of 3 quarters · filed 2025-02-27 | $3.10M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2023-03-31 | -$27.77M 10-Q · filed 2024-05-07 | -$46.31M derived: sum of 2 quarters · filed 2025-02-27 | -$37.09M derived: sum of 3 quarters · filed 2025-02-27 | -$13.29M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2022-12-31 | -$18.54M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$9.31M derived: sum of 2 quarters · filed 2025-02-27 | $14.49M derived: sum of 3 quarters · filed 2025-02-27 | $21.07M 10-K · filed 2025-02-27 | |||
| 2022-09-30 | $9.23M 10-Q · filed 2023-11-02 | $33.03M derived: sum of 2 quarters · filed 2023-11-02 | $39.61M 10-Q · filed 2023-11-02 | $37.40M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2022-06-30 | $23.80M 10-Q · filed 2023-08-02 | $30.38M 10-Q · filed 2023-08-02 | $28.17M derived: sum of 3 quarters · filed 2024-02-29 | $53.34M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2022-03-31 | $6.58M 10-Q · filed 2023-05-03 | $4.37M derived: sum of 2 quarters · filed 2024-02-29 | $29.54M derived: sum of 3 quarters · filed 2024-02-29 | $55.40M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2021-12-31 | -$2.21M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $22.96M derived: sum of 2 quarters · filed 2024-02-29 | $48.82M derived: sum of 3 quarters · filed 2024-02-29 | $64.75M 10-K · filed 2024-02-29 | |||
| 2021-09-30 | $25.17M 10-Q · filed 2022-11-03 | $51.03M derived: sum of 2 quarters · filed 2022-11-03 | $66.96M 10-Q · filed 2022-11-03 | $73.81M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2021-06-30 | $25.86M 10-Q · filed 2022-08-03 | $41.80M 10-Q · filed 2022-08-03 | $48.64M derived: sum of 3 quarters · filed 2023-02-28 | $56.82M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2021-03-31 | $15.93M 10-Q · filed 2022-05-04 | $22.78M derived: sum of 2 quarters · filed 2023-02-28 | $30.95M derived: sum of 3 quarters · filed 2023-02-28 | $24.31M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2020-12-31 | $6.85M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $15.02M derived: sum of 2 quarters · filed 2023-02-28 | $8.38M derived: sum of 3 quarters · filed 2023-02-28 | $17.00M 10-K · filed 2023-02-28 | |||
| 2020-09-30 | $8.18M 10-Q · filed 2021-11-03 | $1.53M derived: sum of 2 quarters · filed 2021-11-03 | $10.15M 10-Q · filed 2021-11-03 | $6.51M derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2020-06-30 | -$6.64M 10-Q · filed 2021-08-03 | $6.40M 10-Q · filed 2021-08-03 | -$1.67M derived: sum of 3 quarters · filed 2022-02-28 | -$4.87M derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2020-03-31 | $9.82M 10-Q · filed 2021-05-04 | $13.05M 10-Q · filed 2020-05-07 | $4.98M derived: sum of 2 quarters · filed 2022-02-28 | $1.77M derived: sum of 3 quarters · filed 2022-02-28 | $5.53M derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2019-12-31 | -$4.84M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$8.05M derived: sum of 2 quarters · filed 2022-02-28 | -$4.29M derived: sum of 3 quarters · filed 2022-02-28 | -$7.03M 10-K · filed 2022-02-28 | -$71.00K 10-K · filed 2020-02-21 | ||
| 2019-09-30 | -$3.21M 10-Q · filed 2020-10-30 | -$3.23M 10-Q · filed 2019-11-08 | $555.00K derived: sum of 2 quarters · filed 2020-10-30 | -$2.18M 10-Q · filed 2020-10-30 | $2.35M 10-Q · filed 2019-11-08 | $14.93M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-06-30 | $3.76M 10-Q · filed 2020-08-06 | $5.58M 10-Q · filed 2020-08-06 | $18.13M derived: sum of 3 quarters · filed 2021-03-01 | $19.97M derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2019-03-31 | $1.82M 10-Q · filed 2020-05-07 | $14.37M derived: sum of 2 quarters · filed 2021-03-01 | $16.21M derived: sum of 3 quarters · filed 2021-03-01 | $16.80M derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2018-12-31 | $12.55M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $14.39M derived: sum of 2 quarters · filed 2021-03-01 | $14.98M derived: sum of 3 quarters · filed 2021-03-01 | $5.17M 10-K · filed 2021-03-01 | |||
| 2018-09-30 | $1.84M 10-Q · filed 2019-11-08 | $2.43M derived: sum of 2 quarters · filed 2019-11-08 | -$7.38M 10-Q · filed 2019-11-08 | -$2.14M derived: sum of 4 quarters · filed 2020-02-21 | |||
| 2018-06-30 | $592.00K 10-Q · filed 2019-08-08 | -$9.22M 10-Q · filed 2019-08-08 | -$3.98M derived: sum of 3 quarters · filed 2020-02-21 | -$10.85M derived: sum of 4 quarters · filed 2020-02-21 | |||
| 2018-03-31 | -$9.81M 10-Q · filed 2019-05-02 | -$4.58M derived: sum of 2 quarters · filed 2020-02-21 | -$11.44M derived: sum of 3 quarters · filed 2020-02-21 | -$30.39M derived: sum of 4 quarters · filed 2020-02-21 | |||
| 2017-12-31 | $5.24M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | -$1.63M derived: sum of 2 quarters · filed 2020-02-21 | -$20.58M derived: sum of 3 quarters · filed 2020-02-21 | -$39.90M 10-K · filed 2020-02-21 | |||
| 2017-09-30 | -$6.87M 10-Q · filed 2018-11-01 | -$25.82M derived: sum of 2 quarters · filed 2018-11-01 | -$45.14M 10-Q · filed 2018-11-01 | -$48.67M derived: sum of 4 quarters · filed 2019-02-28 | |||
| 2017-06-30 | -$18.95M 10-Q · filed 2018-08-02 | -$38.27M 10-Q · filed 2018-08-02 | -$41.80M derived: sum of 3 quarters · filed 2019-02-28 | -$63.58M derived: sum of 4 quarters · filed 2019-02-28 | |||
| 2017-03-31 | -$19.32M 10-Q · filed 2018-05-03 | -$22.85M derived: sum of 2 quarters · filed 2019-02-28 | -$44.63M derived: sum of 3 quarters · filed 2019-02-28 | -$52.16M derived: sum of 4 quarters · filed 2019-02-28 | |||
| 2016-12-31 | -$3.53M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | -$25.31M derived: sum of 2 quarters · filed 2019-02-28 | -$32.84M derived: sum of 3 quarters · filed 2019-02-28 | -$36.34M 10-K · filed 2019-02-28 | |||
| 2016-09-30 | -$21.78M 10-Q · filed 2017-11-08 | -$29.31M derived: sum of 2 quarters · filed 2017-11-08 | -$32.81M 10-Q · filed 2017-11-08 | -$35.06M derived: sum of 4 quarters · filed 2018-02-28 | |||
| 2016-06-30 | -$7.53M 10-Q · filed 2017-08-02 | -$11.03M 10-Q · filed 2017-08-02 | -$13.28M derived: sum of 3 quarters · filed 2018-02-28 | -$9.50M derived: sum of 4 quarters · filed 2018-02-28 | |||
| 2016-03-31 | -$3.50M 10-Q · filed 2017-05-04 | -$5.75M derived: sum of 2 quarters · filed 2018-02-28 | -$1.98M derived: sum of 3 quarters · filed 2018-02-28 | -$1.63M derived: sum of 4 quarters · filed 2018-02-28 | |||
| 2015-12-31 | -$2.25M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $1.52M derived: sum of 2 quarters · filed 2018-02-28 | $1.87M derived: sum of 3 quarters · filed 2018-02-28 | $3.76M 10-K · filed 2018-02-28 | $4.03M 10-K · filed 2016-02-25 | ||
| 2015-09-30 | $3.78M 10-Q · filed 2016-11-02 | $4.13M derived: sum of 2 quarters · filed 2016-11-02 | $6.01M 10-Q · filed 2016-11-02 | -$7.26M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-06-30 | $352.00K 10-Q · filed 2016-08-04 | $2.24M 10-Q · filed 2016-08-04 | -$11.03M derived: sum of 3 quarters · filed 2017-03-01 | -$14.04M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-03-31 | $1.89M 10-Q · filed 2016-05-02 | -$11.38M derived: sum of 2 quarters · filed 2017-03-01 | -$14.39M derived: sum of 3 quarters · filed 2017-03-01 | -$19.43M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2014-12-31 | -$13.27M 10-K · filed 2017-03-01 | -$16.27M derived: sum of 2 quarters · filed 2017-03-01 | -$21.31M derived: sum of 3 quarters · filed 2017-03-01 | -$13.27M 10-K · filed 2016-02-25 | |||
| 2014-09-30 | -$3.00M 10-Q · filed 2015-10-27 | -$8.04M derived: sum of 2 quarters · filed 2015-10-27 | -$19.52M 10-Q · filed 2015-10-27 | ||||
| 2014-06-30 | -$5.04M 10-Q · filed 2015-07-30 | -$16.51M 10-Q · filed 2015-07-30 | |||||
| 2013-12-31 | -$64.35M 10-K · filed 2016-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |